Over his 20-year tenure at Merck & Co., Inc., Eric helped to integrate research and commercial strategies in a number of key therapeutic areas for the company and, working closely with R&D leadership, ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

German companies including Merck and ZEISS expressed strong confidence and high hopes for the Chinese market at the China ...

Merck & Co. said Friday that Canada's Drug Agency recommended the company's Winrevair for reimbursement as a treatment for adults with pulmonary arterial hypertension. The agency recommended the ...

Sotatercept is the first activin signaling inhibitor therapy for PAH in Canada, a new class of therapy that works by improving the balance between pro-proliferative and anti-proliferative signaling to ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

AstraZeneca’s presence in South Africa has become a driving force in global health research, contributing significantly to respiratory, cardiovascular, and oncology therapeutic areas. The ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

Despite Summit's impressive data, Merck is still another biopharma company that's worth buying and holding for at least five ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

Shares of Merck & Co. Inc. MRK inched 0.44% higher to $101.17 Thursday, on what proved to be an all-around mixed trading ...